TIMP1 and renal cell carcinoma: TIMP1, a key tissue inhibitor of metalloproteinase that regulates most matrix metalloproteinases, was usually found to be increased in renal cell carcinoma (RCC) and could affect the efficiency of radiotherapy (Smyth et al., 2007).